Clinical Trials Logo

Delirium clinical trials

View clinical trials related to Delirium.

Filter by:

NCT ID: NCT03379129 Completed - Delirium Clinical Trials

Family ICU Delirium Detection Study

FIDDS
Start date: November 6, 2017
Phase:
Study type: Observational

To evaluate the validity, reliability, and acceptability of employing family-administered delirium detection tools in the critically ill. The ultimate goal of this project is to improve the care of critically ill patients by creating valid, earlier, and patient and family-centered prevention, recognition, and management of delirium.

NCT ID: NCT03366896 Completed - Clinical trials for Postoperative Delirium

Validation Study of the Malay Version of 3D-CAM

VS-MEDCAM
Start date: June 26, 2016
Phase: N/A
Study type: Interventional

Validation of the Malay version of 3D-CAM, involving two-staged process. 1. Translation and cultural adaptation of 3D-CAM into the Malay language. 2. Testing for Validity and Reliability of the translated 3D-CAM tool to detect postoperative delirium.

NCT ID: NCT03360838 Recruiting - Clinical trials for Cognitive Impairment

Development of a Prediction Model for Delirium After Cardiac Surgery Using a Novel Self-Administered Preoperative Cognitive Assessment Tool

CogCheck-Valid
Start date: April 16, 2018
Phase:
Study type: Observational

This observational cohort study is designed to validate the CogCheck application as a risk prediction tool for postoperative delirium in patients undergoing cardiac surgery.

NCT ID: NCT03360474 Withdrawn - Cancer Clinical Trials

Implementation of a Delirium Screening

Start date: June 2018
Phase: N/A
Study type: Interventional

The purpose of this project is to improve patient outcomes in individuals affected by cancer, through the implementation of a delirium screening and treatment protocol in the ICU setting. The hypothesis is that patients who receive an accurate and early diagnosis of delirium coupled with a standardized intervention protocol will demonstrate improved patient outcomes as evidenced by fewer days spent in the ICU, fewer days spent in the hospital (overall length of stay) and the need for less sedative medication throughout their ICU stay as compared to patient data prior to the implementation of a delirium protocol.

NCT ID: NCT03355053 Recruiting - Sleep Clinical Trials

Investigation of Sleep in the Intensive Care Unit

ICU-SLEEP
Start date: June 1, 2018
Phase: Phase 2
Study type: Interventional

Sleep deprivation is common and severe in critically ill patients cared for in intensive care units (ICUs), and is hypothesized to be a key modifiable risk factor for delirium and long-term cognitive disability. Dexmedetomidine reduces the incidence of delirium in ICU patients by unknown mechanisms. This project will determine whether dexmedetomidine reduces delirium by improving sleep, whether bolus dosing vs continuous infusion is better, and the relationship of sleep quality to long-term cognitive outcomes.

NCT ID: NCT03351985 Not yet recruiting - Delirium Clinical Trials

The Study of Post-operation Delirium and Prognosis of Cardiac Surgery Patients

Start date: December 1, 2017
Phase: N/A
Study type: Observational

Delirium is the most common neurological complication of cardiac surgery patients and associated with poor prognosis. In recent years, the important role of quantitative electroencephalogram (qEEG) in brain function monitoring is becoming increasingly prominent. The purpose of this study is to evaluate the effect of qEEG in predictive of post-operation delirium and prognosis of cardiac surgery patients.

NCT ID: NCT03349411 Completed - Stroke Clinical Trials

Spatial Neglect and Delirium After Stroke

Start date: July 18, 2017
Phase:
Study type: Observational [Patient Registry]

The goal of this study is to understand what brain mechanisms become disrupted when stroke survivors experience delirium. Delirium is an acute reduction in attention and cognition, associated with poor recovery, longer hospitalization and even death. One major factor increasing the risk of delirium after stroke may be spatial neglect occurring after stroke on the right side of the brain. Spatial neglect affects awareness, orientation, and movement. The study will test the hypothesis that the right-dominant brain networks for arousal and attention are affected in both of these disorders. It is expected that the activity and structural integrity of these brain networks will correlate with behavioral signs and severity of delirium and spatial neglect. To test this hypothesis, the study will measure spatial neglect and delirium symptoms in 45 acute (NYC Health + Hospitals/Bellevue ) and 30 subacute (Kessler Institute for Rehabilitation) stroke survivors and evaluate brain scans for these participants. This study may contribute to knowledge about brain bio-markers of delirium, which will greatly aid in delirium detection in stroke and other disorders.

NCT ID: NCT03346226 Not yet recruiting - Delirium in Old Age Clinical Trials

How Different Sedatives Affect Hip Fracture Patient's Postoperative Delirium

Start date: January 1, 2018
Phase: Phase 4
Study type: Interventional

the hypothesis is that Dexmedetomidine seems to decrease incidence of post-operative delirium . one possible mechanism is that Dex have a minor influence on cognition, since it has no effect on GABA receptor,another is that Dex could induce a sleep similar to natural sleep, thereby decreasing sleep deprivation and circadian rhythm disorder in post-operative patients. In this study , investigators devise the two different sedatives(Dexmedetomidine and Propofol)'influence on postoperative delirium in hip fracture elderly participants under spinal anesthesia

NCT ID: NCT03342989 Terminated - Dementia Clinical Trials

Speed of Processing Training for Cognitive Deficits After Delirium in Older Adults

Start date: August 13, 2018
Phase: N/A
Study type: Interventional

In this proposal, we will examine processing speed training (PST) as a potential intervention to reduce the risk of developing long-term cognitive impairment after a delirium episode.

NCT ID: NCT03337672 Completed - Tonsillitis Clinical Trials

Comparison of Dexmedetomidine and Midazolam for Prevention of Emergence Delirium in Children

Start date: December 5, 2017
Phase: N/A
Study type: Interventional

Emergence delirium is a common complication in children after anesthesia. The incidence of emergence delirium is reported upto 50%. Prevention of emergence delirium in children is important not only for the patient safety but also for the satisfaction of the parents. Midazolam is the most commonly used medications for prevention of emergence delirium. However, it might lead to delayed awakening from anesthesia and respiratory depression. In this study, the investigators will evaluate whether dexmedetomidine can be effectively and safely administered for prevention of emergence delirium in children compared to midazolam.